Sex-Specific Associations Between Dynapenia and Risk of Atherosclerotic Cardiovascular Disease: A Machine-Learning-Based Approach.

IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Gyumin Lee, Hye-Jin Kim, Heeji Choi, Seung-Ho Shin, Chulho Kim, Sang-Hwa Lee, Jong-Hee Sohn, Jae Jun Lee
{"title":"Sex-Specific Associations Between Dynapenia and Risk of Atherosclerotic Cardiovascular Disease: A Machine-Learning-Based Approach.","authors":"Gyumin Lee, Hye-Jin Kim, Heeji Choi, Seung-Ho Shin, Chulho Kim, Sang-Hwa Lee, Jong-Hee Sohn, Jae Jun Lee","doi":"10.3390/jpm15030083","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives</b>: Dynapenia, age-associated loss in muscle strength, is an emerging risk factor for atherosclerotic cardiovascular disease (ASCVD), which may have different effects depending on sex. This study aims to investigate the association between dynapenia and ASCVD risk, evaluate its predictive significance among traditional factors, and explore sex-specific patterns through machine learning models. <b>Methods</b>: This retrospective case-control study uses data from 19,582 participants aged 40-79 from the Korean National Health and Nutrition Examination Survey (KNHANES). ASCVD risk is assessed using the American College of Cardiology/American Heart Association 10-year risk algorithm, with dynapenia defined based on hand grip strength. Multivariable logistic regression and ML algorithms, including light gradient boosting (LGB) and XGBoost (XGB), are applied to examine predictive factors. Model performance is evaluated via the area under the receiver operating characteristic curve (AUROC), and Shapley additive explanation (SHAP) analysis highlights variable importance. <b>Results</b>: Dynapenia prevalence is higher in women (33.4%) than men (13.9%) at high ASCVD risk. Logistic regression shows dynapenia is significantly associated with high ASCVD risk in women (odds ratio, 1.47; 95% confidence interval, 1.20-1.81) but not in men. Machine learning models demonstrate excellent predictive performance, with XGB achieving the highest AUROC (0.950 in men and 0.963 in women). The SHAP analysis identifies dynapenia as a critical risk factor in women, while body mass index, educational status, and household income are influential in both sexes. <b>Conclusions</b>: Dynapenia is a significant ASCVD risk factor in women, emphasizing sex-specific prevention strategies. Machine learning enhances risk assessment precision, underscoring muscle health's role in cardiovascular care.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"15 3","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11942907/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jpm15030083","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objectives: Dynapenia, age-associated loss in muscle strength, is an emerging risk factor for atherosclerotic cardiovascular disease (ASCVD), which may have different effects depending on sex. This study aims to investigate the association between dynapenia and ASCVD risk, evaluate its predictive significance among traditional factors, and explore sex-specific patterns through machine learning models. Methods: This retrospective case-control study uses data from 19,582 participants aged 40-79 from the Korean National Health and Nutrition Examination Survey (KNHANES). ASCVD risk is assessed using the American College of Cardiology/American Heart Association 10-year risk algorithm, with dynapenia defined based on hand grip strength. Multivariable logistic regression and ML algorithms, including light gradient boosting (LGB) and XGBoost (XGB), are applied to examine predictive factors. Model performance is evaluated via the area under the receiver operating characteristic curve (AUROC), and Shapley additive explanation (SHAP) analysis highlights variable importance. Results: Dynapenia prevalence is higher in women (33.4%) than men (13.9%) at high ASCVD risk. Logistic regression shows dynapenia is significantly associated with high ASCVD risk in women (odds ratio, 1.47; 95% confidence interval, 1.20-1.81) but not in men. Machine learning models demonstrate excellent predictive performance, with XGB achieving the highest AUROC (0.950 in men and 0.963 in women). The SHAP analysis identifies dynapenia as a critical risk factor in women, while body mass index, educational status, and household income are influential in both sexes. Conclusions: Dynapenia is a significant ASCVD risk factor in women, emphasizing sex-specific prevention strategies. Machine learning enhances risk assessment precision, underscoring muscle health's role in cardiovascular care.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Personalized Medicine
Journal of Personalized Medicine Medicine-Medicine (miscellaneous)
CiteScore
4.10
自引率
0.00%
发文量
1878
审稿时长
11 weeks
期刊介绍: Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信